Statins and Diabetes

Abstract

Get full access to this article

View all access options for this article.

References

FDA expands advice on statin risks. http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM293705.pdf. Published February 12, 2012. Accessed February 27, 2013.

Food and Drug Administration. FDA drug safety communication: important safety label changes to cholesterol-lowering statin drugs. http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm. Published February 28, 2012. Accessed February 27, 2013.

Ridker

Pradhan

MacFayden

Libby

Glynn

. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380(9841):565-571.